Usefulness of Combined Metabolic-Volumetric Indices of (18)F-FDG PET/CT for the Early Prediction of Neoadjuvant Chemotherapy Outcomes in Breast Cancer (Q33670107)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Usefulness of Combined Metabolic-Volumetric Indices of (18)F-FDG PET/CT for the Early Prediction of Neoadjuvant Chemotherapy Outcomes in Breast Cancer	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Usefulness of Combined Metabolic-Volumetric Indices of (18)F-FDG PET/CT for the Early Prediction of Neoadjuvant Chemotherapy Outcomes in Breast Cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

based on heuristic

inferred from title

Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography

1 reference

based on heuristic

inferred from title

author name string

Hyung-Jun Im

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Yu Kyeong Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Yong-Il Kim

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Jong Jin Lee

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Won Woo Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Sang Eun Kim

6

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

17 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Nuclear medicine and molecular imaging NMMI

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

36-43

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Prognostic Value of Metabolic Tumor Volume Measured by (18)F-FDG PET/CT in Locally Advanced Head and Neck Squamous Cell Carcinomas Treated by Surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035214

21 June 2018

The Prognostic Value of the Metabolic Tumor Volume in FIGO stage IA to IIB Cervical Cancer for Tumor Recurrence: Measured by F-18 FDG PET/CT.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035214

21 June 2018

Computer-aided evaluation of breast MRI for the residual tumor extent and response monitoring in breast cancer patients receiving neoadjuvant chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035214

21 June 2018

Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035214

21 June 2018

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035214

21 June 2018

Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035214

21 June 2018

Early (18)F-2-fluoro-2-deoxy-d-glucose positron emission tomography may identify a subset of patients with estrogen receptor-positive breast cancer who will not respond optimally to preoperative chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035214

21 June 2018

Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy--systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035214

21 June 2018

Update on locally advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035214

21 June 2018

Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035214

21 June 2018

Early monitoring of response to neoadjuvant chemotherapy in breast cancer with 18F-FDG PET/CT: defining a clinical aim

1 reference

https://api.crossref.org/works/10.1007%2FS13139-012-0181-5

21 January 2018

Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography.

1 reference

https://api.crossref.org/works/10.1007%2FS13139-012-0181-5

21 January 2018

Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose

1 reference

https://api.crossref.org/works/10.1007%2FS13139-012-0181-5

21 January 2018

The role of 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13139-012-0181-5

21 January 2018

18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS13139-012-0181-5

21 January 2018

Metabolic tumor width parameters as determined on PET/CT predict disease-free survival and treatment response in squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1007%2FS13139-012-0181-5

21 January 2018

Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13139-012-0181-5

21 January 2018

18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma

1 reference

https://api.crossref.org/works/10.1007%2FS13139-012-0181-5

21 January 2018

Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI.

1 reference

https://api.crossref.org/works/10.1007%2FS13139-012-0181-5

21 January 2018

Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma.

1 reference

https://api.crossref.org/works/10.1007%2FS13139-012-0181-5

21 January 2018

A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival

1 reference

https://api.crossref.org/works/10.1007%2FS13139-012-0181-5

21 January 2018

Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS13139-012-0181-5

21 January 2018

Monitoring primary breast cancer throughout chemotherapy using FDG-PET.

1 reference

https://api.crossref.org/works/10.1007%2FS13139-012-0181-5

21 January 2018

Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035214

30 October 2018

Relationship between 18F-FDG uptake and breast density in women with normal breast tissue

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035214

30 October 2018

Prognostic significance of metabolic parameters measured by (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24895506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S13139-012-0181-5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33670107&oldid=2246406148"